Unknown

Dataset Information

The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.


ABSTRACT:

Background

Oral immunization with vaccines may be an effective strategy for prevention of Clostridium difficile infection (CDI). However, application of previously developed vaccines for preventing CDI has been limited due to various reasons. Here, we developed a recombinant Lactococcus lactis oral vaccine and evaluated its effect on a C. difficile-infected animal model established in golden hamsters in attempt to provide an alternative strategy for CDI prevention.

Methods

Recombinant L. lactis vaccine was developed using the pTRKH2 plasmid, a high-copy-number Escherichia coli-L. shuttle vector: 1) L. lactis expressing secreted proteins was constructed with recombinant pTRKH2 (secreted-protein plasmid) carrying the Usp45 signal peptide (SPUsp45), nontoxic adjuvanted tetanus

SUBMITTER: Yang XQ 

PROVIDER: S-EPMC3750240 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature